To the Editor:
Two recent publications have given rise to concerns regarding the safety of intraoperative aprotinin on renal function after cardiac surgery. 1, 2 Contrary to these studies, Furnary et al 3 demonstrated that aprotinin does not increase the risk of acute renal failure (ARF) independently of the number of transfusions administered. We have 3 concerns regarding the findings of these studies that impair an adequate comparison of their results.
First, all 3 studies used different definitions for ARF. Furnary et al 3 selected the new requirement of dialysis as the ARF outcome, presumably because the risk predictive score has been validated for ARF requiring dialysis after cardiac surgery. In comparison, Mangano et al 1 Second, because intercurrent events after surgery, for example, radiocontrast and nephrotoxic antibiotics, can all contribute to ARF risk, the time between exposure and outcome needs to be prospectively defined. Karkouti et al 2 limited the time period of analysis to 7 days after surgery, whereas the time period is not clear in the other 2 studies. Consequently, these studies could have included more ARF events unrelated to intraoperative events.
Third, the importance of chronic kidney disease as a risk factor for ARF needs to be considered. Mangano et al 1 and Karkouti et al 2 demonstrated that chronic kidney disease patients had a higher risk of acute renal dysfunction with the use of aprotinin. Over 30% of patients included in the analysis by Furnary et al 3 had elevated baseline creatinine Ն106 mol per liter (1.2 mg/dL); however, it is unclear if these patients had a higher incidence of ARF.
These findings emphasize the importance of a standardized definition of ARF in research. The Acute Kidney Injury Network (AKIN) has proposed a new definition and classification with the goal of improving outcomes from ARF. 4 Recent studies have found that even minor short-term changes in serum creatinine (ie, Ն0.3 mg/dL or 26 mol/L) are linked to increased morbidity and mortality. 5 Thus, acute kidney injury is defined as an absolute increase in serum creatinine of Ն26 mol/L, a 1.5-fold increase in serum creatinine from baseline or oliguria defined as urine output less than 0.5 mL · kg Ϫ1 · h Ϫ1 for at least 6 hours within 48 hours. This definition is currently being validated in several settings, including after cardiac surgery, and we would propose that it could permit comparisons across different studies and settings. We look forward to new analyses from Furnary et al considering (1) 
